ZENI Stock Overview
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Zenicor Medical Systems AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr2.98 |
52 Week High | kr9.10 |
52 Week Low | kr2.80 |
Beta | 1.12 |
1 Month Change | 0% |
3 Month Change | -9.15% |
1 Year Change | -66.89% |
3 Year Change | -78.94% |
5 Year Change | -82.47% |
Change since IPO | -75.97% |
Recent News & Updates
Recent updates
Here's Why Zenicor Medical Systems (NGM:ZENI) Has A Meaningful Debt Burden
Oct 18With EPS Growth And More, Zenicor Medical Systems (NGM:ZENI) Is Interesting
Jan 31Should You Investigate Zenicor Medical Systems AB (publ) (NGM:ZENI) At kr12.40?
Apr 13Are Zenicor Medical Systems AB (publ)'s (NGM:ZENI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Feb 17Shareholder Returns
ZENI | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 0% | -3.4% | -1.6% |
1Y | -66.9% | -13.6% | 7.8% |
Return vs Industry: ZENI underperformed the Swedish Medical Equipment industry which returned -13.6% over the past year.
Return vs Market: ZENI underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
ZENI volatility | |
---|---|
ZENI Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 12.8% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: ZENI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZENI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 23 | Mats Palerius | zenicor.se |
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor-ECG, a system to detect and diagnose atrial fibrillation and other arrhythmias, as well as allows the patient to register ECG data during extended periods and transfer the date to a central ECG database, where the data is presented to the care provider through the Internet. It serves cardiology, stroke, medical, pediatrics, clinical physiology, and private clinics in the Nordics, Germany, Switzerland, Austria, Cyprus, and the Great Britain.
Zenicor Medical Systems AB (publ) Fundamentals Summary
ZENI fundamental statistics | |
---|---|
Market cap | kr26.89m |
Earnings (TTM) | -kr5.59m |
Revenue (TTM) | kr32.26m |
0.8x
P/S Ratio-4.8x
P/E RatioIs ZENI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZENI income statement (TTM) | |
---|---|
Revenue | kr32.26m |
Cost of Revenue | kr3.95m |
Gross Profit | kr28.31m |
Other Expenses | kr33.90m |
Earnings | -kr5.59m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | -0.62 |
Gross Margin | 87.76% |
Net Profit Margin | -17.32% |
Debt/Equity Ratio | 52.3% |
How did ZENI perform over the long term?
See historical performance and comparison